Cargando…
Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871857/ http://dx.doi.org/10.1016/S0992-5945(21)00020-9 |
| _version_ | 1783649094651084800 |
|---|---|
| author | Émile, Carole |
| author_facet | Émile, Carole |
| author_sort | Émile, Carole |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7871857 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78718572021-02-10 Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé Émile, Carole Option/Bio Article Elsevier Masson SAS. 2021 2021-02-09 /pmc/articles/PMC7871857/ http://dx.doi.org/10.1016/S0992-5945(21)00020-9 Text en Copyright © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Émile, Carole Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé |
| title | Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé |
| title_full | Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé |
| title_fullStr | Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé |
| title_full_unstemmed | Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé |
| title_short | Sérologie anti-Sars-CoV-2 : retour d’expérience de la cellule test de la Direction générale de la santé |
| title_sort | sérologie anti-sars-cov-2 : retour d’expérience de la cellule test de la direction générale de la santé |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871857/ http://dx.doi.org/10.1016/S0992-5945(21)00020-9 |
| work_keys_str_mv | AT emilecarole serologieantisarscov2retourdexperiencedelacelluletestdeladirectiongeneraledelasante |